Abstract
Prenatal exposure to antiepileptic drugs (AEDs) increases the risk of major congenital malformations (MCM) in the fetus. AED-related abnormalities include heart and neural tube defects, cleft palate, and urogenital abnormalities. Among the various congenital anomalies of the kidney and urinary tract (CAKUT), multicystic dysplastic kidney (MCDK) disease is one of the most severe expressions. Although prenatal ultrasound (US) examination has increased the prenatal diagnosis of MCDK, the pathogenesis is still unclear. We report on four cases of MCDK in infants of epileptic women treated with AEDs during pregnancy. From October 2003 to June 2006, we observed four infants with unilateral MCDK born to epileptic women. Three patients were considered to have typical features of multicystic dysplastic kidney, and one infant was operated because of a cystic pelvic mass in the absence of a kidney in the left flank. The macroscopic appearance of this mass showed an ectopic multicystic kidney confirmed by histological findings. All patients have been studied by US scans, voiding cystourethrogram (VCUG), and radionuclide screening isotope imaging. The prenatal exposure to AEDs increases the risk of major congenital malformations from the background risk of 1–2% to 4–9%. AEDs may determine a defect in apoptosis regulation that could lead to abnormal nephrogenesis, causing MCDK. Carbamazepine (CBZ) and phenobarbital (PHB) during pregnancy should be used at the lowest dosage compatible with maternal disease. The reduction, or even suspension, of drug dosage should be achieved from the periconceptional period to the first 8 weeks of gestation to avoid any interference with organogenesis.
This is a preview of subscription content, log in via an institution to check access.
References
Holmes LB, Harvey EA, Coull BA, Huntington KB, Khoshbin S, Hayes AM, Ryan LM (2001) The teratogenicity of anticonvulsant drugs. N Eng J Med 344:1132–1138
Pennel PB (2004) Pregnancy in women who have epilepsy. Neurol Clin 22:799–820
Fried S, Kozer E, Nulman I, Einarson TR, Koren G (2004) Malformation rates in children of women with untreated epilepsy; a meta-analysis. Drug Saf 27:197–202
Canger R, Battino D, Canevini MP, Fumarola C, Guidolin L, Vignoli A, Mamoli D, Palmieri C, Molteni F, Granata T, Hassibi P, Zamperini P, Pardi G, Avanzino G (1999) Malformations in offspring of women with epilepsy: a prospective study. Epilepsia 40:1231–1236
Fairgrieve SD, Jackson M, Jonas P, Walshaw D, White K, Montgomery TL, Burn J, Lynch SA (2000) Population based, prospective study of the care of woman with epilepsy in pregnancy. BMJ 321:674–675
Yerby MS (2001) The use of anticonvulsants during pregnancy. Semin Perinatol 25:153–158
Stumpf DA, Frost M (1978) Seizures, anticonvulsants, and pregnancy. Am J Dis Child 132:746–748
Samren EB, van Duijn CM, Christiaens GCML, Hofman A, Lindhout D (1999) Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol 46:739–746
Wide K, Winbladh B, Kallen B (2004) Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepin and valproic acid: a nation-wide, population-based register study. Acta Pediatr 93:174–176
Matalon S, Schechtman S, Godzweig G, Ornoy A (2002) The teratogenic effect of carbamazepine: a meta-analysis of 1255 exposures. Reprod Toxicol 16:9–17
Janz D (1994) Are anti epileptic drugs harmful when taken during pregnancy? J Perinat Med 22:367–375
Lindhout D, Hoppener RJ, Meinardi H (1984) Teratogenicity of antiepileptic drug combinations with special emphasis on epoxidation (of carbamazepine). Epilepsia 25:77–83
Arpino C, Brescianini S, Robert E, Castilla EE, Cocchi G, Cornel MC, de Vigan C, Lancaster PA, Merlob P, Sumiyoshi Y, Zampino G, Renzi C, Rosano A, Mastroiacovo P (2000) Teratogenic effects of antiepileptic drugs: use of an International Database on Malformations and Drug Exposure (MADRE). Epilepsia 41:1436–1443
Hernandez-Diaz S, Werler MM, Walker AM, Allen A (2000) Folic acid antagonists during pregnancy and the risk of birth defects. N Eng J Med 343:1608–1614
Pope JC, Brock JW, Adams MC, Douglas Stephens F, Ichikawa I (1999) How they begin and how they end: classic and new theories for the development and deterioration of congenital anomalies of the kidney and urinary tract, CAKUT. J Am Soc Nephrol 10:2018–2028
Chandler D, El-Naggar AK, Brisbay S, Redline RW, McDonnel TJ (1994) Apoptosis and expression of the bcl-2 proto-oncogene in the fetal and adult human kidney: evidence for the contribution of bcl-2 expression to renal carcinogenesis. Human Pathol 25:789–796
Trudel M, Lanoix J, Barisoni L, Bloudin M, Desforges M, L’Italien C, D’Agati V (1997) C-MYC-induced apoptosis in polycystic kidney disease is Bcl-2 and p53 independent. J Exp Med 186:1873–1884
Sorenson CM, Padanilam BJ, Hammerman MR (1996) Abnormal postpartum renal development and cystogenesis in the bcl-2 (−/−) mouse. Am J Physiol 271:F184–F193
Winyard PJD, Risdon RA, Sams VR, Dressler GR, Woolf AS (1996) The PAX2 transcription factor is expressed in cystic and hyperprofilerative dysplastic epithelia in human kidney malformations. J Clin Invest 98:451–459
Worner W, Schrenk D (1996) Influence of liver tumor promoters on apoptosis in rat hepatocytes induced by 2-acetylaminofluorene, ultraviolet light, or transforming growth factor beta 1. Cancer Res 56:1272–1278
Sanders S, Thorgeirsson SS (1999) Phenobarbital promotes liver growth in c-myc/TGF-a transgenic mice by inducing hypertrophy and inhibiting apoptosis. Carcinogenesis 20:41–49
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Carta, M., Cimador, M., Giuffrè, M. et al. Unilateral multicystic dysplastic kidney in infants exposed to antiepileptic drugs during pregnancy. Pediatr Nephrol 22, 1054–1057 (2007). https://doi.org/10.1007/s00467-007-0446-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-007-0446-x